Details for New Drug Application (NDA): 208912
✉ Email this page to a colleague
The generic ingredient in DEXYCU KIT is dexamethasone. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 208912
Tradename: | DEXYCU KIT |
Applicant: | Eyepoint Pharms |
Ingredient: | dexamethasone |
Patents: | 6 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 208912
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;INTRAOCULAR | Strength | 9% | ||||
Approval Date: | Feb 9, 2018 | TE: | RLD: | Yes | |||||
Patent: | See Plans and Pricing | Patent Expiration: | Jun 22, 2034 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF POSTOPERATIVE INFLAMMATION | ||||||||
Patent: | See Plans and Pricing | Patent Expiration: | May 23, 2034 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF POSTOPERATIVE INFLAMMATION | ||||||||
Patent: | See Plans and Pricing | Patent Expiration: | May 23, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription